APLM
Apollomics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 2
Stock Price Surged Significantly
Price Hits New Low
Price Hits 52-week Low
Bullish Abandoned Baby
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About APLM
Apollomics Inc.
A clinical-stage biotechnology company focused on discovering and developing oncology therapies
989 E. Hillsdale Blvd., Suite 220, Foster City, CA 94404
--
Guanke Meibo Limited was incorporated in the Cayman Islands on May 21, 2015. They are an innovative clinical-stage biotechnology company focused on discovering and developing oncology therapies to meet unmet medical needs. Since their inception in 2015, they have established a pipeline of nine drug candidates in 11 oncology-focused projects, six of which are in the clinical stage.
Company Financials
EPS
APLM has released its 2022 Q1 earnings. EPS was reported at -0.03, versus the expected 0, missing expectations. The chart below visualizes how APLM has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
